Freight Technologies Integrates with Blue Yonder TMS Through Bayer to Optimize Supply Chain Efficiency
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, 'Fr8Tech' or the 'Company'), a logistics management innovation company, is pleased to announce its integration with supply chain management company Blue Yonder's Transportation Management System ('TMS') through Bayer Crop Science LP ('Bayer'). This follows Bayer's selection of Fr8Tech as a key logistics provider in September 2024 for the 2025 season, where Fr8Tech was awarded six critical cross-border lanes for truckload services.
Fr8Tech has integrated its Fr8App platform with Bayer's instance of Blue Yonder through an Electronic Data Interchange ('EDI') to help optimize Bayer's logistics and supply chain management. This direct integration enables automated data exchanges, eliminates manual processes and ensures faster, more accurate communication. Connecting Fr8Tech's logistics platform with Bayer's TMS through EDI will allow for enhanced shipment visibility, reduced lead times and optimized resource allocation - improving overall supply chain efficiency and advancing Bayer's operational goals.
Javier Selgas, CEO of Fr8Tech added, 'This seamless and rapid integration is a testament to Fr8Tech's highly flexible platform solutions, enabling companies like Bayer to achieve greater operational efficiency in their supply chain management. This development also further strengthens Fr8Techs' position as a trusted and leading provider of logistics solutions powered by AI and machine learning.'
About Freight Technologies Inc.
Freight Technologies (Nasdaq: FRGT) ('Fr8Tech") is a technology company offering a diverse portfolio of proprietary platform solutions powered by AI and machine learning to optimize and automate the supply chain process. Focused on addressing the distinct challenges within the supply chain ecosystem, the Company's portfolio of solutions includes the Fr8App platform for seamless OTR B2B cross-border shipping across the USMCA region; Fr8Now, a specialized service for less-than-truckload (LTL) shipping; Fr8Fleet, a dedicated capacity service for enterprise clients in Mexico; Waavely, a digital platform for efficient ocean freight booking and management of container shipments between North America and ports worldwide and Fleet Rocket a nimble, scalable and cost-effective Transportation Management System (TMS) for brokers, shippers, and other logistics operator Together, each product is interconnected within a unified platform to connect carriers and shippers and significantly improve matching and operation efficiency via innovative technologies such as live pricing and real-time tracking, digital freight marketplace, brokerage support, transportation management, fleet management, and committed capacity solutions. The company is headquartered in Houston, Texas. For more information, please visit fr8technologies.com.
Forward-Looking Statements
This press release includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Fr8Tech's and Fr8App Inc.'s actual results may differ from their expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as 'expect,' 'estimate,' 'project,' 'budget,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'may,' 'will,' 'could,' 'should,' 'believes,' 'predicts,' 'potential,' 'continue' and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Fr8Tech's and Fr8App Inc.'s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the inability to obtain or maintain the listing of Fr8Tech's ordinary shares on Nasdaq; (2) changes in applicable laws or regulations; (3) the possibility that Fr8Tech or Fr8App Inc. may be adversely affected by other economic, business and/or competitive factors; (4) risks relating to the uncertainty of the projected financial information with respect to Fr8App Inc.; (5) risks related to the organic and inorganic growth of Fr8App Inc.'s business and the timing of expected business milestones; and (6) other risks and uncertainties identified, including those under 'Risk Factors,' to be filed in Fr8Tech other filings with the Securities Exchange Commission.
Fr8Tech cautions that the foregoing list of factors is not exclusive. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Fr8Tech and Fr8App Inc. caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Fr8Tech and Fr8App Inc. do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based.
CONTACT: Fr8Tech Contact: Jason Finkelstein IGNITION Investor Relations investors@fr8technologies.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Drug maker Indivior to abandon London stock market for the US
Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company to abandon the UK market for the US. However, the LSE welcomes Anglo-American's platinum spin-off Valterra after becoming independent from the mining giant. Indivior's exit comes after the company moved its primary listing to the US's Nasdaq index last year. It said cancelling the secondary listing in London eliminates 'cost and complexity' and better reflects the business – with more than 80% of its revenues generated in the US. It also said liquidity on the Nasdaq now 'far outweighs' that of the LSE with a greater level of trading. The US-based pharmaceutical firm makes prescription medicines to treat opioid addiction, and has a market capitalisation of £1.2 billion. 'A single primary listing on Nasdaq best reflects the profile of Indivior's business,' chairman David Wheadon said. 'We appreciate the support received from shareholders for this initiative and look forward to capitalising on the expected benefits of this move, including reductions in cost and complexity.' The LSE faced the largest exodus of companies since the global financial crisis in 2024, according to EY analysis. There were 88 companies to delist or transfer their primary listing from the main market – the most since 2009. At the same time, the LSE struggled to attract as many new companies to fill the gaps – with 18 new listings in total last year. Nevertheless, Indivior's exit, which will take effect from July 25, comes as Valterra Platinum makes its debut on the London market. Anglo American spun off its platinum business into the new entity, which has become the world's most valuable producer of the metal. Valterra will have its secondary listing on the LSE, with its primary on the Johannesburg Stock Exchange. Duncan Wanblad, Anglo American's chief executive, said: 'Valterra Platinum has been a major part of the company for many years but now is the right time for it to optimise its value creation prospects on an independent path – it's an outstanding business and team and I have every confidence that Valterra Platinum will thrive as a leader in the global platinum group metals industry.' Sign in to access your portfolio
Yahoo
34 minutes ago
- Yahoo
Ollie's (OLLI) Reports Q1: Everything You Need To Know Ahead Of Earnings
Discount retail company Ollie's Bargain Outlet (NASDAQ:OLLI) will be announcing earnings results tomorrow before the bell. Here's what you need to know. Ollie's missed analysts' revenue expectations by 1.2% last quarter, reporting revenues of $667.1 million, up 2.8% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' gross margin estimates but full-year EPS guidance missing analysts' expectations. Is Ollie's a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Ollie's revenue to grow 11.3% year on year to $566.2 million, in line with the 10.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.71 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Ollie's has missed Wall Street's revenue estimates four times over the last two years. Looking at Ollie's peers in the discount retailer segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the discount retailer segment, with share prices up 9.8% on average over the last month. Ollie's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $125.88 (compared to the current share price of $110). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Couchbase (BASE) Q1 Earnings: What To Expect
Database as a service company Couchbase (NASDAQ: BASE) will be reporting results tomorrow after the bell. Here's what to expect. Couchbase beat analysts' revenue expectations by 3.1% last quarter, reporting revenues of $54.92 million, up 9.6% year on year. It was a satisfactory quarter for the company, with an impressive beat of analysts' billings estimates but full-year guidance of slowing revenue growth. Is Couchbase a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Couchbase's revenue to grow 8.2% year on year to $55.56 million, slowing from the 25.2% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.08 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Couchbase has missed Wall Street's revenue estimates twice over the last two years. Looking at Couchbase's peers in the data storage segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Commvault Systems delivered year-on-year revenue growth of 23.2%, beating analysts' expectations by 4.8%, and Snowflake reported revenues up 25.7%, topping estimates by 3.4%. Commvault Systems's stock price was unchanged after the resultswhile Snowflake was up 13.5%. Read our full analysis of Commvault Systems's results here and Snowflake's results here. There has been positive sentiment among investors in the data storage segment, with share prices up 7.6% on average over the last month. Couchbase's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $20.81 (compared to the current share price of $17.61). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
